Pharmacol Res. 2021 Aug 30:105863. doi: 10.1016/j.phrs.2021.105863. Online ahead of print.
NO ABSTRACT
PMID:34474101 | DOI:10.1016/j.phrs.2021.105863
Categories
Response to the comment on “SGLT-2 inhibitors reduce the risk of cerebrovascular/cardiovascular outcomes and mortality: a systematic review and meta-analysis of retrospective cohort studies”
